![]() ![]() A nurse also called to offer injection training-she’ll be on hand for my first injection to show me exactly what to do. The pharmacy called me about a week later to arrange delivery. I filled out the paperwork through my doctor, who submitted it to the Aimovig Ally pharmacy. (My first doses are through the two-month free trial. See page 4 of this Aimovig prescription form for the legalese. Participants will receive two months of Aimovig (either 70 mg or 140 mg each month, depending on what your doctor prescribes) at no charge. ![]() The two-month free trial is available to all new Aimovig patients (except those who live in Massachusetts or have participated in a clinical trial). And I’d love if you leave a comment sharing what you learn so we can all know more about the programs! How to Pay for Aimovig, #1: Two-Month Aimovig Free Trial I found their customer service incredibly helpful and responsive. If you have questions, please call Aimovig Ally at (833) 246-6844. My knowledge on these programs is limited to what I’ve shared here. Note: You may be eligible for several different programs, so be sure to read through all the options. Tomorrow I’ll talk about insurance coverage, which is looking quite promising for patients with commercial coverage. Those are two of Amgen’s four programs to help pay for Aimovig, only one of which requires demonstrated financial need. If my insurance won’t cover it after that, Amgen will pay for up to another 12 months of doses while I go through the insurance appeal process. My first two doses are coming free through Amgen’s two-month free-trial. My insurance isn’t covering it yet (though some insurance companies are), but I’m not paying for it either. Monitor patients treated with Aimovig ® for new-onset hypertension, or worsening of pre-existing hypertension, and consider whether discontinuation of Aimovig ® is warranted if evaluation fails to establish an alternative etiology.Īdverse Reactions: The most common adverse reactions in clinical studies (≥ 3% of Aimovig ®-treated patients and more often than placebo) were injection site reactions and constipation.How to pay for Aimovig? Will insurance cover it? How am I paying for my first dose? These are the questions I got when I posted the delivery date of my Aimovig to Facebook. Aimovig ® was discontinued in many of the reported cases. In the majority of the cases, the onset or worsening of hypertension was reported after the first dose. Hypertension may occur at any time during treatment but was most frequently reported within seven days of dose administration. There were cases requiring pharmacological treatment and, in some cases, hospitalization. Many of the patients had pre-existing hypertension or risk factors for hypertension. Hypertension: Development of hypertension and worsening of pre-existing hypertension have been reported following the use of Aimovig ® in the postmarketing setting. Concurrent use of medications associated with decreased gastrointestinal motility may increase the risk for more severe constipation and the potential for constipation-related complications. Monitor patients treated with Aimovig ® for severe constipation and manage as clinically appropriate. Constipation was one of the most common (up to 3%) adverse reactions reported in clinical studies. Aimovig ® was discontinued in most reported cases. The onset of constipation was reported after the first dose in a majority of these cases, but patients also reported later on in treatment. There were cases that required hospitalization, including cases where surgery was necessary. If a serious or severe reaction occurs, discontinue Aimovig ® and initiate appropriate therapy.Ĭonstipation with Serious Complications: Constipation with serious complications has been reported following the use of postmarketing setting. Most reactions were not serious and occurred within hours of administration, although some occurred more than one week after administration. Hypersensitivity Reactions: Hypersensitivity reactions, including rash, angioedema, and anaphylaxis, have been reported with Aimovig ® in post marketing experience. Reactions have included anaphylaxis and angioedema. IMPORTANT SAFETY INFORMATIONĬontraindication: Aimovig ® is contraindicated in patients with serious hypersensitivity to erenumab-aooe or to any of the excipients. Aimovig ® (erenumab-aooe) is indicated for the preventive treatment of migraine in adults. ![]()
0 Comments
Leave a Reply. |